title: Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
abstract: A thymidine kinase (TK)-negative (TK-) deletion mutant of the Bucharest (BUK) strain of pseudorabies virus (PRV) was isolated. The mutant, designated as PRV (BUK d13), did not revert to TK-positive (TK+), even when propagated in medium that selected for TK+ viruses. The mutant also replicated equally well at 39.1 C and 34.5 C, and was easily distinguished from other PRV strains by molecular hybridization experiments, restriction nuclease fingerprints, and plaque autoradiography or other assays for the TK phenotype. The PRV (BUK d13) had greatly reduced virulence for mice and rabbits, compared with parental TK+ strains, PRV (BUK-5) and PRV (BUK-5A-R1), and provided mice with solid protection against the TK+ BUK and Aujeszky strains of PRV. Experiments were done in 5- to 6-week-old pigs to assess the safety and efficacy of PRV (BUK d13) in the natural host. In one experiment, pigs were vaccinated IM with 7.5 X 10(8) plaque-forming units of TK- PRV (BUK d13), and were then challenge exposed intranasally (IN) with 4.3 X 10(8) TCID50 of virulent PRV [Indiana-Funkhauser (IND-F)]. Vaccinated pigs did not have clinical signs of illness after vaccination or after challenge exposure. One nonvaccinated control pig died on postchallenge day 4; a 2nd nonvaccinated control pig became moribund, but eventually recovered. Pigs developed virus-neutralizing antibodies after vaccination, and had a secondary immunologic response after challenge exposure; however, PRV was not isolated from the tonsils or trigeminal ganglia of vaccinated pigs at postchallenge exposure day 11.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.forename: S
authors.initials: S
authors.lastname: Kit
authors.forename: M
authors.initials: M
authors.lastname: Kit
authors.forename: E C
authors.initials: EC
authors.lastname: Pirtle
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002460:Cell Line; D005260:Female; D005347:Fibroblasts; D011558:Herpesvirus 1, Suid / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D005779:Immunodiffusion / Q000662:veterinary; D051379:Mice; D009154:Mutation; D009500:Neutralization Tests; D009693:Nucleic Acid Hybridization; D011817:Rabbits; D012867:Skin; D013552:Swine / Q000276:immunology; D013937:Thymidine Kinase / Q000235:genetics*; D014611:Vaccination / Q000662:veterinary; D010948:Viral Plaque Assay / Q000379:methods; D014774:Virulence; D014776:Virus Cultivation
chemical_list: D000914:Antibodies, Viral; D013937:Thymidine Kinase